naltrexone and Hypergonadotropic Hypogonadism

naltrexone has been researched along with Hypergonadotropic Hypogonadism in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Alzaharani, SY; Antony, T; El-Ghaiesh, SH	1
Aronne, LJ; Igel, LI; Kumar, RB; Saunders, KH	1
Blomenröhr, M; García-Galiano, D; Gaytan, F; Krajnc-Franken, MA; Leon, S; Manfredi-Lozano, M; Navarro, VM; Pinilla, L; Romero-Ruiz, A; Tena-Sempere, M; van Ingen Schenau, D; van Noort, PI	1
Franks, S; Gilling-Smith, C	1

Reviews

3 review(s) available for naltrexone and Hypergonadotropic Hypogonadism

Article	Year
Opioid-induced hypogonadism: Pathophysiology, clinical and therapeutics review. Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:5 Topics: Analgesics, Opioid; Animals; Drug Administration Schedule; Female; Fertility; Gonadal Steroid Hormones; Gonads; Hormone Replacement Therapy; Humans; Hypogonadism; Infertility; Male; Naltrexone; Narcotic Antagonists; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Time Factors	2020
Practical Use of Pharmacotherapy for Obesity. Gastroenterology, 2017, Volume: 152, Issue:7 Topics: Androgens; Anti-Obesity Agents; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Appetite Depressants; Benzazepines; Bupropion; Drug Combinations; Fructose; Humans; Hypoglycemic Agents; Hypogonadism; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Testosterone; Topiramate; Weight Gain	2017
Advances in induction of ovulation. Current opinion in obstetrics & gynecology, 1994, Volume: 6, Issue:2 Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome	1994

Other Studies

1 other study(ies) available for naltrexone and Hypergonadotropic Hypogonadism

Article	Year
Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice. Endocrinology, 2012, Volume: 153, Issue:1 Topics: Adamantane; Animals; Dipeptides; Follicle Stimulating Hormone; Galanin-Like Peptide; Glutamic Acid; Gonadotropin-Releasing Hormone; Gonadotropins; Hypogonadism; Kisspeptins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Models, Neurological; Naltrexone; Neurokinin B; Peptide Fragments; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Signal Transduction; Substance P; Testosterone	2012

Article

Year

Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice.

Endocrinology, 2012, Volume: 153, Issue:1

Topics: Adamantane; Animals; Dipeptides; Follicle Stimulating Hormone; Galanin-Like Peptide; Glutamic Acid; Gonadotropin-Releasing Hormone; Gonadotropins; Hypogonadism; Kisspeptins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Models, Neurological; Naltrexone; Neurokinin B; Peptide Fragments; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Signal Transduction; Substance P; Testosterone

2012